Estimaciones de analistas de Wall Street para HeartBeam, Inc. (BEAT): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 9 |
| Mantener | 4 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 13 |
| Calificación media (1-5) | 0.69 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.10 | ||
| 2026-08-13 | $-0.10 | $-0.09 | -16.3% |
| 2026-05-13 | $-0.12 | $-0.14 | +14.3% |
| 2026-03-12 | $-0.14 | $-0.13 | -7.7% |
| 2025-11-13 | $-0.15 | $-0.16 | +6.3% |
| 2025-08-13 | $-0.15 | $-0.16 | +6.3% |
| 2025-05-13 | $-0.18 | $-0.15 | -20.0% |
| 2025-03-13 | $-0.18 | $-0.19 | +5.3% |
Ratios de valoración
| Precio / Valor contable | 2.64 |
| EV / EBITDA | -0.74 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $208.3M | $286.8M | $399.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $78.9M | $114.4M | $149.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | $129.4M | $172.4M | $250.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $8.4M | $11.1M | $11.2M | $41000 | $133000 | $255000 | $5.7M | $6.8M | $11.1M | $13.4M |
| Generales y Administrativos | $85.2M | $123.9M | $155.3M | $253000 | $655000 | $2.0M | $7.4M | $8.5M | $8.8M | $7.7M |
| Gastos Operativos | $93.6M | $135.0M | $166.5M | $294000 | $788000 | $2.3M | $13.0M | $15.3M | $19.9M | $21.1M |
| Beneficio Operativo | $35.9M | $37.4M | $84.0M | -$294000 | -$788000 | -$2.3M | -$13.0M | -$15.3M | -$19.9M | -$21.1M |
| EBITDA | $30.0M | $24.2M | $92.0M | 0 | 0 | -$2.3M | $69000 | $675000 | -$19.4M | -$21.0M |
| Gastos por Intereses | 0 | $4.9M | $9.4M | $242000 | $280000 | $2.2M | $66000 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | $15.8M | -$10.4M | $41.5M | -$536000 | -$1.1M | -$4.4M | -$13.0M | -$14.6M | -$19.4M | -$21.0M |
| Impuestos | -$37.7M | $6.7M | -$370000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | $53.4M | -$16.0M | $42.8M | -$536000 | -$1.1M | -$4.4M | -$13.0M | -$14.6M | -$19.4M | -$21.0M |
| BPA | $1.91 | $-0.53 | $1.20 | $-0.10 | $-0.14 | $-0.56 | $-1.59 | $-0.72 | $-0.73 | $-0.62 |
| BPA Diluido | $1.75 | $-0.53 | $1.20 | $-0.10 | $-0.14 | $-0.56 | $-1.59 | $-0.72 | $-0.73 | $-0.62 |
| Acciones en Circulación (Diluidas) | $30.5M | $30.4M | $35.8M | $8.2M | $8.2M | $7.8M | $8.2M | $20.3M | $26.6M | $33.7M |
Precio
| Precio | $0.41 |
| Capitalización | $23M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CRVO · EQ · HOWL · INKT · IOBT · MDAI · ONMD
Explorar sector: Healthcare · Medical - Specialties
Más secciones de BEAT: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones